A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design

BACKGROUND: Radiation therapy for diffuse large B‐cell lymphoma (DLBCL) has shown improvement in progression free survival. There is uncertainty about the optimal radiation dose, with heterogeneous doses being used, ranging from 30 to 55 Gy. This trial tests the efficacy of using reduced radiation d...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Rep (Hoboken)
Päätekijät: Goda, Jayant S., Lewis, Shirly C., Laskar, Siddartha, Kannan, Sadhna, Khanna, Nehal, Jain, Hasmukh, Bagal, Bhausaheb, Epari, Sridhar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Registered Report Stage 1: Study Design
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941552/
https://ncbi.nlm.nih.gov/pubmed/32935480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1161
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia